Attached files

file filename
EX-32 - EXHIBIT 32 - Summit Healthcare REIT, Inctm2021635d1_ex32.htm
EX-31.2 - EXHIBIT 31.2 - Summit Healthcare REIT, Inctm2021635d1_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - Summit Healthcare REIT, Inctm2021635d1_ex31-1.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q/A

Amendment No. 1

 

(Mark One)

  x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2020

 

  ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number 000-52566

 

SUMMIT HEALTHCARE REIT, INC. AND SUBSIDIARIES

(Exact name of registrant as specified in its charter)

 

MARYLAND 73-1721791
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)

 

2 SOUTH POINTE DRIVE, SUITE 100,

LAKE FOREST, CA

92630
(Address of principal executive offices) (Zip Code)

 

800-978-8136

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Ticker symbol(s) Name of each exchange on which registered
N/A N/A N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes  ¨ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Sec. 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). x Yes  ¨ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨ Accelerated filer ¨
       
Non-accelerated filer x  Smaller reporting company x
       
Emerging growth company ¨     

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ¨ Yes x No

 

As of May 6, 2020, we had 23,027,978 shares of common stock of Summit Healthcare REIT, Inc. outstanding.

 

 

 

 

 

 

 EXPLANATORY NOTE

 

Summit Healthcare REIT, Inc. (the “Company”) is filing this Amendment No. 1 (this “Form 10-Q/A”) to its quarterly report on Form 10-Q for the period ended March 31, 2020 (the “Form 10-Q”), filed with the U.S. Securities and Exchange Commission (the “SEC”) on May 14, 2020, solely to correct a typographical error in the heading of the Company’s Condensed Consolidated Statements of Operations (Unaudited), set forth in Part I, Item 1 of the Form 10-Q. The dates in the columns of the heading were reversed in the Form 10-Q. The heading has been corrected in the Condensed Consolidated Statements of Operations included with this Form 10-Q/A.

 

In connection with the filing of this Form 10-Q/A and pursuant to the SEC’s rules, the Company is including with this Form 10-Q/A new certifications by its principal executive officer and principal financial officer.

 

This Form 10-Q/A should be read in conjunction with the Form 10-Q, which remains in effect as of its date. Except as specifically noted above and herein, this Form 10-Q/A does not modify or update disclosures in the Form 10-Q. Accordingly, this Form 10-Q/A does not reflect events occurring after the filing of the Form 10-Q or modify or update any related or other disclosures.

 

 2 

 

   

SUMMIT HEALTHCARE REIT, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

 

  

Three Months Ended 

March 31,

 
   2020   2019 
Revenues:          
Total rental revenues  $1,600,000    2,079,000 
Acquisition and asset management fees   326,000    210,000 
Interest income from notes receivable   7,000    6,000 
 Total operating revenue   1,933,000    2,295,000 
           
Expenses:          
Property operating costs   257,000    294,000 
General and administrative   939,000    1,275,000 
Depreciation and amortization   417,000    499,000 
 Total operating expenses   1,613,000    2,068,000 
           
Other operating income:          
Gain on sale of real estate properties   -    4,147,000 
Operating income   320,000    4,374,000 
           
Income from equity-method investees   30,000    130,000 
Other income   42,000    52,000 
Interest expense   (593,000)   (756,000)
Net (loss) income   (201,000)   3,800,000 
Noncontrolling interests’ share in net (income) loss   (12,000)   123,000 
Net (loss) income applicable to common stockholders  $(213,000)   3,923,000 
           
Earnings per common share:          
Basic:          
(Loss) income  $(0.01)  $0.17 
Net (loss) income applicable to common stockholders  $(0.01)  $0.17 
           
Diluted:          
(Loss) income  $(0.01)  $0.17 
Net (loss) income applicable to common stockholders  $(0.01)  $0.17 
           
Weighted average shares used to calculate earnings per common share:          
Basic   23,027,978    23,027,978 
Diluted   23,027,978    23,513,331 

 

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

 

 3 

 

   

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Amendment No. 1 to its quarterly report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SUMMIT HEALTHCARE REIT, INC.
   
  /s/ Kent Eikanas
Date: June 2, 2020 Kent Eikanas
  Chief Executive Officer
(Principal Executive Officer)
   
  /s/ Elizabeth A. Pagliarini
Date: June 2, 2020 Elizabeth A. Pagliarini
  Chief Financial Officer
(Principal Financial Officer)

  

 4